Role of Scavenger Receptor A and CD36 in Diet-Induced Nonalcoholic Steatohepatitis in Hyperlipidemic Mice

被引:147
作者
Bieghs, Veerle [1 ,2 ]
Wouters, Kristiaan [1 ,2 ]
Van Gorp, Patrick J. [1 ,2 ]
Gijbels, Marion J. J. [1 ,2 ]
De Winther, Menno P. J. [1 ,2 ]
Binder, Christoph J. [3 ,4 ]
Luetjohann, Dieter [5 ]
Febbraio, Maria [6 ]
Moore, Kathryn J. [7 ]
Van Bilsen, Marc [1 ,2 ]
Hofker, Marten H. [8 ]
Shiri-Sverdlov, Ronit [1 ,2 ]
机构
[1] Univ Maastricht, Nutr & Toxicol Res NUTRIM, Dept Mol Genet Pathol & Physiol, NL-6200 MD Maastricht, Netherlands
[2] Univ Maastricht, Cardiovasc Res CARIM Inst Maastricht, NL-6200 MD Maastricht, Netherlands
[3] Med Univ Vienna, Dept Med & Chem Lab Diagnost, Vienna, Austria
[4] Austrian Acad Sci, Ctr Mol Med, A-1010 Vienna, Austria
[5] Univ Bonn, Inst Clin Chem & Pharmacol, D-5300 Bonn, Germany
[6] Lerner Res Inst, Dept Cell Biol, Cleveland, OH USA
[7] NYU, Med Ctr, Leon H Charney Div Cardiol, New York, NY 10016 USA
[8] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Lab Med, NL-9700 AB Groningen, Netherlands
关键词
Fatty Liver; Inflammation; Scavenger Receptors; Kupffer Cells; LOW-DENSITY-LIPOPROTEIN; BRAIN CHOLESTEROL-SYNTHESIS; FOAM CELL-FORMATION; OXIDIZED LDL; ATHEROSCLEROSIS; INFLAMMATION; AUTOANTIBODIES; EXPRESSION; PHAGOCYTOSIS; SIMVASTATIN;
D O I
10.1053/j.gastro.2010.02.051
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Nonalcoholic steatohepatitis (NASH) is a disorder that consists of steatosis and hepatic inflammation. It is not known why only some people with steatosis develop NASH. Recently, we identified dietary cholesterol as a factor that directly leads to hepatic inflammation and hepatic foam cell formation. We propose a mechanism by which Kupffer cells (KCs) take up modified cholesterol-rich lipoproteins via scavenger receptors (SRs). KCs thereby accumulate cholesterol, become activated, and may then trigger an inflammatory reaction. Scavenging of modified lipoproteins mainly depends on CD36 and macrophage scavenger receptor 1. METHODS: To evaluate the involvement of SR-mediated uptake of modified lipoproteins by KCs in the development of diet-induced NASH, female low-density lipoprotein receptor-deficient (Ldlr(-/-)) mice were lethally irradiated and transplanted with bone marrow from Msr1(+/+)/Cd36(+/+) or Msr1(-/-)/Cd36(-/-) mice and fed a Western diet. RESULTS: Macrophage and neutrophil infiltration revealed that hepatic inflammation was substantially reduced by approximately 30% in Msr1(-/-)/Cd36(-/-) -transplanted mice compared with control mice. Consistent with this, the expression levels of well-known inflammatory mediators were reduced. Apoptotis and fibrosis were less pronounced in Msr1(-/-) /Cd36(-/-) -transplanted mice, in addition to the protective phenotype of natural antibodies against oxidized low-density lipoprotein in the plasma. Surprisingly, the effect on hepatic inflammation was independent of foam cell formation. CONCLUSIONS: Targeted inactivation of SR pathways reduces the hepatic inflammation and tissue destruction associated with NASH, independent of hepatic foam cell formation.
引用
收藏
页码:2477 / U351
页数:13
相关论文
共 48 条
  • [1] Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis
    Albano, E
    Mottaran, E
    Vidali, M
    Reale, E
    Saksena, S
    Occhino, G
    Burt, AD
    Day, CP
    [J]. GUT, 2005, 54 (07) : 987 - 993
  • [2] IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis
    Binder, CJ
    Hartvigsen, K
    Chang, MK
    Miller, M
    Broide, D
    Palinski, W
    Curtiss, LK
    Corr, M
    Witztum, JL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (03) : 427 - 437
  • [3] Molecular mediators of hepatic steatosis and liver injury
    Browning, JD
    Horton, JD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02) : 147 - 152
  • [4] Canbay Ali, 2005, Turk J Gastroenterol, V16, P1
  • [5] Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans
    Chou, Meng-Yun
    Fogelstrand, Linda
    Hartvigsen, Karsten
    Hansen, Lotte F.
    Woelkers, Douglas
    Shaw, Peter X.
    Choi, Jeomil
    Perkmann, Thomas
    Backhed, Fredrik
    Miller, Yury I.
    Hoerkkoe, Sohvi
    Corr, Maripat
    Witztum, Joseph L.
    Binder, Christoph J.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (05) : 1335 - 1349
  • [6] The class A macrophage scavenger receptor attenuates CXC chemokine production and the early infiltration of neutrophils in sterile peritonitis
    Cotena, A
    Gordon, S
    Platt, N
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (10) : 6427 - 6432
  • [7] CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism
    Febbraio, M
    Hajjar, DP
    Silverstein, RL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (06) : 785 - 791
  • [8] Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor α agonists via inhibition of CCAAT box/enhancer-binding protein β
    Gervois, P
    Vu-Dac, N
    Kleemann, R
    Kockx, M
    Dubois, G
    Laine, B
    Kosykh, V
    Fruchart, JC
    Kooistra, T
    Staels, B
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (36) : 33471 - 33477
  • [9] CD36 is a sensor of diacylglycerides
    Hoebe, K
    Georgel, P
    Rutschmann, S
    Du, X
    Mudd, S
    Crozat, K
    Sovath, S
    Shamel, L
    Hartung, T
    Zähringer, U
    Beutler, B
    [J]. NATURE, 2005, 433 (7025) : 523 - 527
  • [10] Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins
    Hörkkö, S
    Bird, DA
    Miller, E
    Itabe, H
    Leitinger, N
    Subbanagounder, G
    Berliner, JA
    Friedman, P
    Dennis, EA
    Curtiss, LK
    Palinski, W
    Witztum, JL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (01) : 117 - 128